Analog Engine CPB · Last run: 21d ago (stale)
NEUTRAL·Trend (~3 months) · 52% win rate
Base +0.3% → $19.47 · Bull +5.9% → $20.55 · Bear -5.4% → $18.37
Entry: $19.41 · Stop: $18.37 · R/R: 0.1:1
RiskWhale Composite Signal
Scenarios
52% win · base +0.3% · trend
BEARISH_DOWNTREND
+8.7% to base target
BULL REGIME · Consumer Staples sector
Trade setup
SKIP
No favorable entry — composite signal suggests standing aside.
$19.41
$18.37
$19.47
0.1:1
CPB Forensic analysis
Detailed research
PART 1: TRADING EXECUTION
Trading Setup & Entry Strategy
- >Entry Zone: $19.99 – $20.10. The stock is hovering just above the lower Bollinger Band support of $19.99. We look for a rejection of this level to establish a long position.
- >Stop Loss: $19.50 (Hard). Positioned below the recent swing low and psychological support.
- >Position Sizing: 2% of portfolio. Treat as a high-conviction mean-reversion trade.
- >Scaling Strategy: Enter 50% at current levels (~$20.20), add 50% on a test of $19.99.
- >Take Profit: 50% at $20.80 (near 20-day SMA), 50% at $21.05 (near 50-day SMA).
- >Risk/Reward: 1:2.3 based on a $0.70 entry-to-exit target vs $0.50 risk.
- >Max Hold Time: 5 Days.
Executive Summary
CPB is currently in a BEARISH_DOWNTREND, trading significantly below its 200-day SMA ($27.69). While fundamentals are under pressure from tariff-related margin contraction and volume headwinds, the stock is showing signs of exhaustion near the lower Bollinger Band ($19.99). Current rating is HOLD due to the technical downtrend, pending a breakout above the 10-day SMA ($20.51).
PART 2: DETAILED RESEARCH
Recent Material Events (8-K)
Recent filings indicate active management of debt, specifically the issuance of $550M in 4.55% notes due 2031 to address maturity walls. The acquisition of La Regina (49%) for $286M is a strategic move to internalize the production of the high-growth Rao's brand.
Insider Trading Activity
Recent Form 4 filings (March/April 2026) appear related to routine compensation-based equity grants/vesting rather than opportunistic open-market accumulation. No signal for a major turnaround here.
Financial Health
- >Revenue Quality: Revenue declined 5% YoY to $2.56B in Q2.
- >Margin Compression: Gross margin fell to 28.0% from 30.5%, largely driven by tariff impacts and supply chain cost inflation.
- >Leverage: Debt/EBITDA remains elevated, though the company is actively managing maturities.
Technical Analysis & Trade Timing
- >Trend: BEARISH_DOWNTREND. Price is below all major SMAs.
- >Momentum: MACD is showing a slight BULLISH histogram crossover (+0.0118), suggesting potential for a short-term relief rally (mean reversion).
- >RSI: 40.12 (Neutral). Room to move higher before reaching overbought levels.
Short-Term Trading Strategy (2-5 Days)
- >Timeframe: Swing Trade (2–5 Days)
- >Catalyst: Market is currently pricing in peak pessimism regarding inflation/tariffs; any stability in upcoming data may spark a cover-rally.
- >Risk Warning: Do not hold through the June 8th earnings release unless a clear uptrend is established above the 50-day SMA.
Investment Recommendation
HOLD. The technical setup suggests a potential oversold bounce, but the fundamental backdrop of declining volumes and margin pressure warrants caution. High-conviction entry is only confirmed upon a reclaim of the 50-day SMA at $21.06.
Thesis: A defensive play on a dividend-paying consumer staple that is currently pricing in maximum margin risk; we play the mean-reversion, not the trend.